Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Advanced NSCLC × Clear all

Phase

Status

Recruiting 5 Terminated 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 847 Carcinoma, Non-Small-Cell Lung 554 Prostatic Neoplasms 501 Neoplasms 501 Colorectal Neoplasms 308 Lung Neoplasms 304 Multiple Myeloma 298 Neoplasm Metastasis 258 Melanoma 246 Ovarian Neoplasms 218 Pancreatic Neoplasms 212 Leukemia, Myeloid, Acute 210 Squamous Cell Carcinoma of Head and Neck 175 Carcinoma, Renal Cell 164 Stomach Neoplasms 162 Recurrence 161 Lymphoma 161 Brain Neoplasms 160 Carcinoma, Hepatocellular 157 Glioblastoma 152 Head and Neck Neoplasms 151 Lymphoma, Non-Hodgkin 143 Triple Negative Breast Neoplasms 138 Leukemia, Lymphocytic, Chronic, B-Cell 136 Uterine Cervical Neoplasms 133 Precursor Cell Lymphoblastic Leukemia-Lymphoma 133 Urinary Bladder Neoplasms 132 Colonic Neoplasms 119 Hematologic Neoplasms 117 Sarcoma 116

Interventions

Oxaliplatin 1 Nivolumab 1 Ipilimumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡